Tumiclas, Alin .

HRN: 12-33-36  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/01/2024
MUPIROCIN 2%, 15G (TUBE)
09/01/2024
09/07/2024
TOPICAL
12%, 15g
BID
S/P Cesarean Section
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: